“The established heart conditions that now affect the poorest billion persons in the world — rheumatic heart disease, cardiomyopathies, malignant hypertension — have, like tuberculosis, receded from the epidemiology and the consciousness of countries like the United States.”
Early 20th-century cardiovascular voluntary organizations in the United States drew strength from the well-established antituberculosis movement. By mid-century, heart disease among the young and tuberculosis had declined in this country. The international fight against tuberculosis has gathered force since the 1990s. Meanwhile, support for international cardiovascular interventions has lagged behind. We trace the divergent path of the international cardiovascular movement and suggest ways in which it could once again learn from the trials and achievements of tuberculosis control.